Quoin Pharmaceuticals annual free cash flow
2017
2019
2020
Quoin Pharmaceuticals Free Cash Flow (FCF) History (QNRX)
Quoin Pharmaceuticals reported −$1.4M in free cash flow for fiscal 2020, a decrease of $106,775 from the previous fiscal year.
View full Quoin Pharmaceuticals company overviewQuoin Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2020 | 2020-12-31 | −$1.4M | −$106,775 | — | — |
| 2019 | 2019-12-31 | −$1.3M | $3.9M | — | — |
| 2017 | 2017-12-31 | −$5.2M | — | — | — |
Quoin Pharmaceuticals quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Quoin Pharmaceuticals free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Quoin Pharmaceuticals filings at SEC.gov ↗